世界の抗がん剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Anticancer Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0377
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、抗がん剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（標的薬、細胞毒性薬、ホルモン薬、その他）、用途別市場規模（免疫療法、標的療法、化学療法、ホルモン療法、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・抗がん剤の市場動向
・企業の競争状況、市場シェア
・抗がん剤の種類別市場規模（標的薬、細胞毒性薬、ホルモン薬、その他）
・抗がん剤の用途別市場規模（免疫療法、標的療法、化学療法、ホルモン療法、その他）
・抗がん剤の北米市場規模2016-2027（アメリカ、カナダ）
・抗がん剤のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・抗がん剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・抗がん剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・抗がん剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Roche、Celgene、Pfizer、Bristol-Myers Squibb、Novartis、AstraZeneca、Teva Pharmaceuticals、Bayer、GlaxoSmithKline）
・結論

Anticancer Drugs are used to treat malignancies, or cancerous growths. Drug therapy may be used alone, or in combination with other treatments such as surgery or radiation therapy.
Anticancer drugs are agents that demonstrate activity against malignant disease. They include alkylating agents, antimetabolites, natural products, and hormones, as well as a variety of other chemicals that do not fall within these discrete classes but are capable of preventing the replication of cancer cells and thus are used in the treatment of cancer.

Market Analysis and Insights: Global Anticancer Drug Market
The global Anticancer Drug market size is projected to reach US$ 145010 million by 2026, from US$ 91410 million in 2019, at a CAGR of 6.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anticancer Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anticancer Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anticancer Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anticancer Drug market.

Global Anticancer Drug Scope and Market Size
Anticancer Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anticancer Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Targeted Drugs
Cytotoxic Drugs
Hormonal Drugs
Others

Segment by Application
Immunotherapy
Targeted Therapy
Chemotherapy
Hormonal Therapy
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Celgene
Pfizer
Bristol-Myers Squibb
Novartis
AstraZeneca
Teva Pharmaceuticals
Bayer
GlaxoSmithKline

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anticancer Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Targeted Drugs
1.2.3 Cytotoxic Drugs
1.2.4 Hormonal Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anticancer Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Immunotherapy
1.3.3 Targeted Therapy
1.3.4 Chemotherapy
1.3.5 Hormonal Therapy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anticancer Drug Market Perspective (2016-2027)
2.2 Anticancer Drug Growth Trends by Regions
2.2.1 Anticancer Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anticancer Drug Historic Market Share by Regions (2016-2021)
2.2.3 Anticancer Drug Forecasted Market Size by Regions (2022-2027)
2.3 Anticancer Drug Industry Dynamic
2.3.1 Anticancer Drug Market Trends
2.3.2 Anticancer Drug Market Drivers
2.3.3 Anticancer Drug Market Challenges
2.3.4 Anticancer Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anticancer Drug Players by Revenue
3.1.1 Global Top Anticancer Drug Players by Revenue (2016-2021)
3.1.2 Global Anticancer Drug Revenue Market Share by Players (2016-2021)
3.2 Global Anticancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anticancer Drug Revenue
3.4 Global Anticancer Drug Market Concentration Ratio
3.4.1 Global Anticancer Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anticancer Drug Revenue in 2020
3.5 Anticancer Drug Key Players Head office and Area Served
3.6 Key Players Anticancer Drug Product Solution and Service
3.7 Date of Enter into Anticancer Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anticancer Drug Breakdown Data by Type
4.1 Global Anticancer Drug Historic Market Size by Type (2016-2021)
4.2 Global Anticancer Drug Forecasted Market Size by Type (2022-2027)

5 Anticancer Drug Breakdown Data by Application
5.1 Global Anticancer Drug Historic Market Size by Application (2016-2021)
5.2 Global Anticancer Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anticancer Drug Market Size (2016-2027)
6.2 North America Anticancer Drug Market Size by Type
6.2.1 North America Anticancer Drug Market Size by Type (2016-2021)
6.2.2 North America Anticancer Drug Market Size by Type (2022-2027)
6.2.3 North America Anticancer Drug Market Size by Type (2016-2027)
6.3 North America Anticancer Drug Market Size by Application
6.3.1 North America Anticancer Drug Market Size by Application (2016-2021)
6.3.2 North America Anticancer Drug Market Size by Application (2022-2027)
6.3.3 North America Anticancer Drug Market Size by Application (2016-2027)
6.4 North America Anticancer Drug Market Size by Country
6.4.1 North America Anticancer Drug Market Size by Country (2016-2021)
6.4.2 North America Anticancer Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Anticancer Drug Market Size (2016-2027)
7.2 Europe Anticancer Drug Market Size by Type
7.2.1 Europe Anticancer Drug Market Size by Type (2016-2021)
7.2.2 Europe Anticancer Drug Market Size by Type (2022-2027)
7.2.3 Europe Anticancer Drug Market Size by Type (2016-2027)
7.3 Europe Anticancer Drug Market Size by Application
7.3.1 Europe Anticancer Drug Market Size by Application (2016-2021)
7.3.2 Europe Anticancer Drug Market Size by Application (2022-2027)
7.3.3 Europe Anticancer Drug Market Size by Application (2016-2027)
7.4 Europe Anticancer Drug Market Size by Country
7.4.1 Europe Anticancer Drug Market Size by Country (2016-2021)
7.4.2 Europe Anticancer Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anticancer Drug Market Size (2016-2027)
8.2 Asia-Pacific Anticancer Drug Market Size by Type
8.2.1 Asia-Pacific Anticancer Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anticancer Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anticancer Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Anticancer Drug Market Size by Application
8.3.1 Asia-Pacific Anticancer Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anticancer Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anticancer Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Anticancer Drug Market Size by Region
8.4.1 Asia-Pacific Anticancer Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anticancer Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anticancer Drug Market Size (2016-2027)
9.2 Latin America Anticancer Drug Market Size by Type
9.2.1 Latin America Anticancer Drug Market Size by Type (2016-2021)
9.2.2 Latin America Anticancer Drug Market Size by Type (2022-2027)
9.2.3 Latin America Anticancer Drug Market Size by Type (2016-2027)
9.3 Latin America Anticancer Drug Market Size by Application
9.3.1 Latin America Anticancer Drug Market Size by Application (2016-2021)
9.3.2 Latin America Anticancer Drug Market Size by Application (2022-2027)
9.3.3 Latin America Anticancer Drug Market Size by Application (2016-2027)
9.4 Latin America Anticancer Drug Market Size by Country
9.4.1 Latin America Anticancer Drug Market Size by Country (2016-2021)
9.4.2 Latin America Anticancer Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anticancer Drug Market Size (2016-2027)
10.2 Middle East & Africa Anticancer Drug Market Size by Type
10.2.1 Middle East & Africa Anticancer Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anticancer Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anticancer Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Anticancer Drug Market Size by Application
10.3.1 Middle East & Africa Anticancer Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anticancer Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anticancer Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Anticancer Drug Market Size by Country
10.4.1 Middle East & Africa Anticancer Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anticancer Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Anticancer Drug Introduction
11.1.4 Roche Revenue in Anticancer Drug Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Anticancer Drug Introduction
11.2.4 Celgene Revenue in Anticancer Drug Business (2016-2021)
11.2.5 Celgene Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Anticancer Drug Introduction
11.3.4 Pfizer Revenue in Anticancer Drug Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Anticancer Drug Introduction
11.4.4 Bristol-Myers Squibb Revenue in Anticancer Drug Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Anticancer Drug Introduction
11.5.4 Novartis Revenue in Anticancer Drug Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Anticancer Drug Introduction
11.6.4 AstraZeneca Revenue in Anticancer Drug Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Company Details
11.7.2 Teva Pharmaceuticals Business Overview
11.7.3 Teva Pharmaceuticals Anticancer Drug Introduction
11.7.4 Teva Pharmaceuticals Revenue in Anticancer Drug Business (2016-2021)
11.7.5 Teva Pharmaceuticals Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Anticancer Drug Introduction
11.8.4 Bayer Revenue in Anticancer Drug Business (2016-2021)
11.8.5 Bayer Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Anticancer Drug Introduction
11.9.4 GlaxoSmithKline Revenue in Anticancer Drug Business (2016-2021)
11.9.5 GlaxoSmithKline Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anticancer Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Targeted Drugs
Table 3. Key Players of Cytotoxic Drugs
Table 4. Key Players of Hormonal Drugs
Table 5. Key Players of Others
Table 6. Global Anticancer Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Anticancer Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Anticancer Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Anticancer Drug Market Share by Regions (2016-2021)
Table 10. Global Anticancer Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Anticancer Drug Market Share by Regions (2022-2027)
Table 12. Anticancer Drug Market Trends
Table 13. Anticancer Drug Market Drivers
Table 14. Anticancer Drug Market Challenges
Table 15. Anticancer Drug Market Restraints
Table 16. Global Anticancer Drug Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Anticancer Drug Market Share by Players (2016-2021)
Table 18. Global Top Anticancer Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticancer Drug as of 2020)
Table 19. Ranking of Global Top Anticancer Drug Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Anticancer Drug Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Anticancer Drug Product Solution and Service
Table 23. Date of Enter into Anticancer Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anticancer Drug Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Anticancer Drug Revenue Market Share by Type (2016-2021)
Table 27. Global Anticancer Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Anticancer Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Anticancer Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Anticancer Drug Revenue Market Share by Application (2016-2021)
Table 31. Global Anticancer Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Anticancer Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Anticancer Drug Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Anticancer Drug Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Anticancer Drug Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Anticancer Drug Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Anticancer Drug Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Anticancer Drug Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Anticancer Drug Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Anticancer Drug Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Anticancer Drug Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Anticancer Drug Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Anticancer Drug Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Anticancer Drug Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Anticancer Drug Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Anticancer Drug Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anticancer Drug Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Anticancer Drug Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Anticancer Drug Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Anticancer Drug Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Anticancer Drug Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Anticancer Drug Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Anticancer Drug Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Anticancer Drug Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Anticancer Drug Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Anticancer Drug Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Anticancer Drug Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Anticancer Drug Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anticancer Drug Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Anticancer Drug Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Anticancer Drug Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Anticancer Drug Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Anticancer Drug Product
Table 66. Roche Revenue in Anticancer Drug Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Celgene Company Details
Table 69. Celgene Business Overview
Table 70. Celgene Anticancer Drug Product
Table 71. Celgene Revenue in Anticancer Drug Business (2016-2021) & (US$ Million)
Table 72. Celgene Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Anticancer Drug Product
Table 76. Pfizer Revenue in Anticancer Drug Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Bristol-Myers Squibb Company Details
Table 79. Bristol-Myers Squibb Business Overview
Table 80. Bristol-Myers Squibb Anticancer Drug Product
Table 81. Bristol-Myers Squibb Revenue in Anticancer Drug Business (2016-2021) & (US$ Million)
Table 82. Bristol-Myers Squibb Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Anticancer Drug Product
Table 86. Novartis Revenue in Anticancer Drug Business (2016-2021) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. AstraZeneca Company Details
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Anticancer Drug Product
Table 91. AstraZeneca Revenue in Anticancer Drug Business (2016-2021) & (US$ Million)
Table 92. AstraZeneca Recent Development
Table 93. Teva Pharmaceuticals Company Details
Table 94. Teva Pharmaceuticals Business Overview
Table 95. Teva Pharmaceuticals Anticancer Drug Product
Table 96. Teva Pharmaceuticals Revenue in Anticancer Drug Business (2016-2021) & (US$ Million)
Table 97. Teva Pharmaceuticals Recent Development
Table 98. Bayer Company Details
Table 99. Bayer Business Overview
Table 100. Bayer Revenue in Anticancer Drug Business (2016-2021) & (US$ Million)
Table 101. Bayer Recent Development
Table 102. GlaxoSmithKline Company Details
Table 103. GlaxoSmithKline Business Overview
Table 104. GlaxoSmithKline Anticancer Drug Product
Table 105. GlaxoSmithKline Revenue in Anticancer Drug Business (2016-2021) & (US$ Million)
Table 106. GlaxoSmithKline Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anticancer Drug Market Share by Type: 2020 VS 2027
Figure 2. Targeted Drugs Features
Figure 3. Cytotoxic Drugs Features
Figure 4. Hormonal Drugs Features
Figure 5. Others Features
Figure 6. Global Anticancer Drug Market Share by Application: 2020 VS 2027
Figure 7. Immunotherapy Case Studies
Figure 8. Targeted Therapy Case Studies
Figure 9. Chemotherapy Case Studies
Figure 10. Hormonal Therapy Case Studies
Figure 11. Others Case Studies
Figure 12. Anticancer Drug Report Years Considered
Figure 13. Global Anticancer Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Anticancer Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Anticancer Drug Market Share by Regions: 2020 VS 2027
Figure 16. Global Anticancer Drug Market Share by Regions (2022-2027)
Figure 17. Global Anticancer Drug Market Share by Players in 2020
Figure 18. Global Top Anticancer Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticancer Drug as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Anticancer Drug Revenue in 2020
Figure 20. Global Anticancer Drug Revenue Market Share by Type (2016-2021)
Figure 21. Global Anticancer Drug Revenue Market Share by Type (2022-2027)
Figure 22. North America Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Anticancer Drug Market Share by Type (2016-2027)
Figure 24. North America Anticancer Drug Market Share by Application (2016-2027)
Figure 25. North America Anticancer Drug Market Share by Country (2016-2027)
Figure 26. United States Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Anticancer Drug Market Share by Type (2016-2027)
Figure 30. Europe Anticancer Drug Market Share by Application (2016-2027)
Figure 31. Europe Anticancer Drug Market Share by Country (2016-2027)
Figure 32. Germany Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Anticancer Drug Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Anticancer Drug Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Anticancer Drug Market Share by Region (2016-2027)
Figure 42. China Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Anticancer Drug Market Share by Type (2016-2027)
Figure 50. Latin America Anticancer Drug Market Share by Application (2016-2027)
Figure 51. Latin America Anticancer Drug Market Share by Country (2016-2027)
Figure 52. Mexico Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Anticancer Drug Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Anticancer Drug Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Anticancer Drug Market Share by Country (2016-2027)
Figure 58. Turkey Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Anticancer Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Roche Revenue Growth Rate in Anticancer Drug Business (2016-2021)
Figure 62. Celgene Revenue Growth Rate in Anticancer Drug Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Anticancer Drug Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Anticancer Drug Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Anticancer Drug Business (2016-2021)
Figure 66. AstraZeneca Revenue Growth Rate in Anticancer Drug Business (2016-2021)
Figure 67. Teva Pharmaceuticals Revenue Growth Rate in Anticancer Drug Business (2016-2021)
Figure 68. Bayer Revenue Growth Rate in Anticancer Drug Business (2016-2021)
Figure 69. GlaxoSmithKline Revenue Growth Rate in Anticancer Drug Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の小売薬市場規模・現状・予測（2021年-2027年）

Global Retail Drug Market Size, Status and Forecast 2021-2027
QYR2104Z5016 2021年4月 96Pages
QYResearch社発行の本調査資料では、小売薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ジェネリック医薬品、OTC医薬品、その他）、用途別市場規模（病院、診療所、家庭用）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界のアレルギー性鼻炎治療薬市場規模・現状・予測（2021年-2027年）

Global Allergy Rhinitis Drug Market Size, Status and Forecast 2021-2027
QYR2104Z0246 2021年4月 95Pages
QYResearch社発行の本調査資料では、アレルギー性鼻炎治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、スプレー）、用途別市場規模（病院、クリニック、医療センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界のドラッグリポジショニング市場規模・現状・予測（2021年-2027年）

Global Drug Repurposing Market Size, Status and Forecast 2021-2027
QYR2104Z1992 2021年4月 96Pages
QYResearch社発行の本調査資料では、ドラッグリポジショニングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍、中枢神経系疾患、神経変性疾患、その他）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリ...

世界のドラッグデリバリー市場規模・現状・予測（2021年-2027年）

Global Drug Discovery Market Size, Status and Forecast 2021-2027
QYR2104Z1983 2021年4月 99Pages
QYResearch社発行の本調査資料では、ドラッグデリバリーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（小分子薬、生物製剤）、用途別市場規模（研究所、製薬会社、バイオテクノロジー会社）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界のドラッグデリバリーにおけるナノテクノロジー市場規模・現状・予測（2021年-2027年）

Global Nanotechnology in Drug Delivery Market Size, Status and Forecast 2021-2027
QYR2104Z4016 2021年4月 91Pages
QYResearch社発行の本調査資料では、ドラッグデリバリーにおけるナノテクノロジーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（標的化送達、薬剤パッケージ）、用途別市場規模（がん、腫瘍、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の薬物乱用検査サービス市場規模・現状・予測（2021年-2027年）

Global Drug of Abuse Testing Services Market Size, Status and Forecast 2021-2027
QYR2104Z1989 2021年4月 92Pages
QYResearch社発行の本調査資料では、薬物乱用検査サービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アルコール、大麻、コカイン、オピオイド、アンフェタミン、LSD、その他）、用途別市場規模（病院、研究所、その他）、主要地域別市場規模...

世界のドラッグリポジショニング市場規模・現状・予測（2021年-2027年）

Global Drug Repositioning Market Size, Status and Forecast 2021-2027
QYR2104Z1990 2021年4月 98Pages
QYResearch社発行の本調査資料では、ドラッグリポジショニングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、静脈内）、用途別市場規模（中枢神経障害、心血管障害、腫瘍、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界のドラッグデリバリー技術市場規模・現状・予測（2021年-2027年）

Global Drug Discovery Technologies Market Size, Status and Forecast 2021-2027
QYR2104Z1986 2021年4月 94Pages
QYResearch社発行の本調査資料では、ドラッグデリバリー技術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（バイオチップ、ハイスループットスクリーニング、薬理ゲノミクス、ゲノミクス、生物分析機器、バイオインフォマティクス、ナノテクノロジー...

世界の薬物乱用（DOA）検査市場規模・現状・予測（2021年-2027年）

Global Drug of Abuse (DOA) Testing Market Size, Status and Forecast 2021-2027
QYR2104Z1987 2021年4月 97Pages
QYResearch社発行の本調査資料では、薬物乱用（DOA）検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（尿、唾液、髪、その他）、用途別市場規模（病院、研究所、職場、家庭、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界のドラッグリプロファイリング市場規模・現状・予測（2021年-2027年）

Global Drug Reprofiling Market Size, Status and Forecast 2021-2027
QYR2104Z1991 2021年4月 90Pages
QYResearch社発行の本調査資料では、ドラッグリプロファイリングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、静脈内）、用途別市場規模（中枢神経障害、心血管障害、腫瘍、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の抗がん剤市場 2021：企業別、地域別、種類・用途別 The Anticancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
世界の胃がん治療薬市場規模・現状・予測（2021年-2027年） Gastric Carcinomas is a cancer of the gastric mucosa. Early symptoms include heartburn, upper abdominal pain, nausea, and loss of appetite. Symptoms are similar to those of peptic ulcers, leading to delayed treatment and a high mortality rate. Market Analysis and Insights: Global Gastric Carcinomas …
世界の画期的治療薬市場規模・現状・予測（2021年-2027年） Breakthrough therapy drugs are intended to treat serious and life-threatening conditions. The breakthrough therapy is the designation given by FDA for the drugs when there is a preliminary clinical evidence indicates that the drug proves a substantial improvement over available drug treatment. Two f…
世界の小分子標的がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Cancer Therapy Market The global Small Molecule Targeted Cancer Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
世界の抗腫瘍薬市場規模・現状・予測（2021年-2027年） Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chem…